BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Merck
Fuji
Express Scripts
Cerilliant
Daiichi Sankyo
Boehringer Ingelheim
Moodys
Chubb
Novartis

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,500,964

« Back to Dashboard

Which drugs does patent 7,500,964 protect, and when does it expire?

Patent 7,500,964 protects ZOLADEX and is included in two NDAs.

This patent has forty-seven patent family members in thirty-three countries.
Summary for Patent: 7,500,964
Title:Automatically operable safety shield system for syringes
Abstract:An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger.
Inventor(s): Shaw; Derek J. (Cheshire, GB), Law; Brian R. (Leicester, GB)
Assignee: AstraZeneca AB (
Application Number:11/740,598
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent 7,500,964

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,500,964

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0003790.3Feb 18, 2000

Non-Orange Book US Patents Family Members for Patent 7,500,964

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,118,552 Automatically operable safety shield system for syringes ➤ Subscribe
7,220,247 Automatically operable safety shield system for syringes ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,500,964

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan 500616 ➤ Subscribe
Slovakia 287563 ➤ Subscribe
Slovakia 11812002 ➤ Subscribe
Slovenia 1259274 ➤ Subscribe
Russian Federation 2234341 ➤ Subscribe
Russian Federation 2002124770 ➤ Subscribe
Portugal 1259274 ➤ Subscribe
Poland 199979 ➤ Subscribe
Poland 357237 ➤ Subscribe
New Zealand 520174 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Chubb
Healthtrust
QuintilesIMS
Farmers Insurance
Novartis
Daiichi Sankyo
Dow
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot